|
DE19824922A1
(de)
|
1998-06-04 |
1999-12-09 |
Boehringer Ingelheim Pharma |
Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
|
GB9910807D0
(en)
|
1999-05-10 |
1999-07-07 |
Prometic Biosciences Limited |
Novel detoxification agents and their use
|
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
|
CA2406562C
(en)
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Hiv replication inhibiting pyrimidines and triazines
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
AU2002316421B2
(en)
|
2001-06-26 |
2008-05-15 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-ALPHA expression
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
JP4460292B2
(ja)
|
2001-10-17 |
2010-05-12 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
ピリミジン誘導体、これらの化合物を含む医薬組成物、その使用及びその調製方法
|
|
JP4072615B2
(ja)
|
2002-03-05 |
2008-04-09 |
独立行政法人産業技術総合研究所 |
配位子を有する複素環化合物及びその製造方法、及びこの複素環化合物を用いる金属元素の固定化膜
|
|
WO2004048343A1
(en)
|
2002-11-28 |
2004-06-10 |
Schering Aktiengesellschaft |
Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
|
CL2004000303A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
|
ES2317031T3
(es)
|
2003-07-16 |
2009-04-16 |
Janssen Pharmaceutica Nv |
Derivados de triazolopirimidina como inhibidores de la glucogeno-sintasa-quinasa 3.
|
|
ES2421139T3
(es)
|
2003-07-30 |
2013-08-29 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
|
|
DK1663242T3
(da)
|
2003-08-07 |
2011-08-01 |
Rigel Pharmaceuticals Inc |
2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
|
|
JP4812763B2
(ja)
|
2004-05-18 |
2011-11-09 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
|
|
EA011671B1
(ru)
|
2004-06-04 |
2009-04-28 |
Арена Фармасьютикалз, Инк. |
Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
CA2592118C
(en)
|
2004-12-23 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Urea derivatives as enzyme modulators
|
|
ATE472327T1
(de)
|
2005-01-07 |
2010-07-15 |
Hoffmann La Roche |
Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
|
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
US8748627B2
(en)
|
2006-02-15 |
2014-06-10 |
Abbvie Inc. |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
|
JP2009537520A
(ja)
|
2006-05-15 |
2009-10-29 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Fgf受容体キナーゼ阻害剤のための組成物および方法
|
|
AU2007257650A1
(en)
|
2006-06-15 |
2007-12-21 |
Boehringer Ingelheim International Gmbh |
2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
CN101611035A
(zh)
|
2006-12-28 |
2009-12-23 |
大正制药株式会社 |
吡唑并嘧啶化合物
|
|
WO2008140895A1
(en)
|
2007-04-20 |
2008-11-20 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
CA2703203C
(en)
|
2007-10-22 |
2015-12-15 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
US20100056524A1
(en)
|
2008-04-02 |
2010-03-04 |
Mciver Edward Giles |
Compound
|
|
PE20100087A1
(es)
|
2008-06-25 |
2010-02-08 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa
|
|
US20110098221A1
(en)
|
2008-06-26 |
2011-04-28 |
Hong Lin |
INHIBITORS OF Akt ACTIVITY
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
AU2009262068C1
(en)
|
2008-06-27 |
2015-07-02 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
|
CA2742007C
(en)
|
2008-10-29 |
2014-07-08 |
Deciphera Pharmaceuticals, Llc |
Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2010111406A2
(en)
|
2009-03-24 |
2010-09-30 |
Myriad Pharmaceuticals, Inc. |
Compounds and therapeutic uses thereof
|
|
US8410126B2
(en)
|
2009-05-29 |
2013-04-02 |
Boehringer Ingelheim International Gmbh |
Pyrimidine inhibitors of PKTK2
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
PH12012500097A1
(en)
|
2009-07-21 |
2011-01-27 |
Shanghai Inst Organic Chem |
Potent small molecule inhibitors of autophagy, and methods of use thereof
|
|
AU2010331927B2
(en)
|
2009-12-17 |
2013-10-10 |
Merck Canada Inc. |
Aminopyrimidines as Syk inhibitors
|
|
WO2011082285A1
(en)
|
2009-12-30 |
2011-07-07 |
Avila Therapeutics, Inc. |
Ligand-directed covalent modification of protein
|
|
BR112012027743A2
(pt)
|
2010-04-29 |
2017-03-14 |
Deciphera Pharmaceuticals Llc |
ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas
|
|
EP2563773A1
(en)
|
2010-04-29 |
2013-03-06 |
Deciphera Pharmaceuticals, LLC |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites
|
|
AU2011260323A1
(en)
|
2010-06-04 |
2012-11-15 |
F. Hoffmann-La Roche Ag |
Aminopyrimidine derivatives as LRRK2 modulators
|
|
JPWO2012033195A1
(ja)
|
2010-09-10 |
2014-01-20 |
京都薬品工業株式会社 |
複素環化合物
|
|
KR101566091B1
(ko)
|
2010-11-10 |
2015-11-04 |
에프. 호프만-라 로슈 아게 |
Lrrk2 조절제로서 피라졸 아미노피리미딘 유도체
|
|
WO2012110773A1
(en)
|
2011-02-17 |
2012-08-23 |
Cancer Therapeutics Crc Pty Limited |
Fak inhibitors
|
|
WO2013014162A1
(en)
*
|
2011-07-28 |
2013-01-31 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as jak inhibitors
|
|
HK1202450A1
(zh)
|
2011-11-22 |
2015-10-02 |
Deciphera Pharmaceuticals, Llc. |
表現出抗癌和抗增殖活性的吡啶酮酰胺以及類似物
|
|
US8791130B2
(en)
|
2011-11-29 |
2014-07-29 |
Genentech, Inc. |
Aminopyrimidine derivatives as LRRK2 modulators
|
|
US9145402B2
(en)
|
2011-11-29 |
2015-09-29 |
Genentech, Inc. |
Aminopyrimidine derivatives as LRRK2 modulators
|
|
WO2013079496A1
(en)
|
2011-11-30 |
2013-06-06 |
F. Hoffmann-La Roche Ag |
Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2
|
|
CN103159736B
(zh)
|
2011-12-10 |
2015-05-13 |
通化济达医药有限公司 |
取代的吡唑激酶抑制剂
|
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
|
US9187474B2
(en)
|
2012-03-07 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014086102A1
(zh)
|
2012-12-06 |
2014-06-12 |
山东亨利医药科技有限责任公司 |
作为酪氨酸激酶抑制剂的吲哚满酮衍生物
|
|
WO2014145029A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
US9012635B2
(en)
|
2013-03-15 |
2015-04-21 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
CN105120864B
(zh)
|
2013-03-15 |
2017-05-17 |
德西费拉制药有限责任公司 |
表现出抗癌活性和抗增殖活性的2‑氨基嘧啶‑6‑酮及类似物
|
|
US9133183B2
(en)
|
2013-03-15 |
2015-09-15 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
US9193719B2
(en)
|
2013-03-15 |
2015-11-24 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
BR112015022263B1
(pt)
|
2013-03-15 |
2023-01-03 |
Deciphera Pharmaceuticals Llc |
N-acil-n-(piridin-2-il) uréias e análogos apresentando atividades anticâncer e antiproliferativas, seus usos, e composição farmacêutica
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2,4取代嘧啶类化合物及其药物组合物与应用
|
|
AU2014287209B2
(en)
|
2013-07-09 |
2019-01-24 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
|
RU2650512C2
(ru)
|
2013-09-18 |
2018-04-16 |
Бейджин Ханми Фармасьютикал Ко., Лтд. |
Соединение, ингибирующее активности киназ ВТК и/или JAK3
|
|
WO2015039613A1
(zh)
|
2013-09-18 |
2015-03-26 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
|
SG11201602069WA
(en)
|
2013-10-18 |
2016-04-28 |
Eisai R&D Man Co Ltd |
Pyrimidine fgfr4 inhibitors
|
|
US10329270B2
(en)
|
2013-10-21 |
2019-06-25 |
Merck Patent Gmbh |
Heteroaryl compounds as BTK inhibitors and uses thereof
|
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
|
WO2015123722A1
(en)
|
2014-02-19 |
2015-08-27 |
Bionomics Limited |
Inhibitors
|
|
US20150284341A1
(en)
|
2014-04-07 |
2015-10-08 |
Catylix, Inc. |
Fluoroalkyl-substituted derivatives of pyridine, pyrimidine, and pyrazine
|
|
ES2914099T3
(es)
*
|
2014-08-25 |
2022-06-07 |
Salk Inst For Biological Studi |
Inhibidores novedosos de ULK1 y métodos de uso de los mismos
|
|
US20170291890A1
(en)
*
|
2014-09-17 |
2017-10-12 |
Epizyme, Inc. |
Heterocycle substituted amino-pyridine compounds and methods of use thereof
|
|
EP3056202A1
(en)
|
2015-02-16 |
2016-08-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Benzopyrrolidone derivatives possessing antiviral and anticancer properties
|
|
WO2016135163A1
(en)
|
2015-02-25 |
2016-09-01 |
F. Hoffmann-La Roche Ag |
Alkynyl alcohols and methods of use
|
|
EP3328496A4
(en)
|
2015-08-02 |
2018-12-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ack1/tnk2 tyrosine kinase
|
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
|
US11028080B2
(en)
*
|
2016-03-11 |
2021-06-08 |
Denali Therapeutics Inc. |
Substituted pyrimidines as LRKK2 inhibitors
|
|
CN108239069B
(zh)
|
2016-12-26 |
2021-01-05 |
南京药捷安康生物科技有限公司 |
一种用于成纤维细胞生长因子受体的抑制剂及其用途
|
|
EP3589284A4
(en)
|
2017-02-28 |
2020-12-16 |
The General Hospital Corporation |
USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS
|
|
BR112019025346A2
(pt)
|
2017-05-30 |
2020-06-30 |
Deciphera Pharmaceuticals, Inc. |
uso de 1-[4-bromo-5-[1-etil-7-(metilamino)-2-oxo-1,2-dihidro-1,6-naftiridin-3-il]-2-fluorofenil]-3-fenilureia e análogos para o tratamento de cânceres associados a anormalidades genéticas no receptor alfa do fator de crescimento derivado de plaquetas
|
|
CN109535132B
(zh)
*
|
2017-09-21 |
2021-07-20 |
北京赛特明强医药科技有限公司 |
2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
|
|
CN118903436A
(zh)
|
2018-01-31 |
2024-11-08 |
德西费拉制药有限责任公司 |
治疗肥大细胞增多症的组合疗法
|
|
HRP20230125T1
(hr)
|
2018-03-27 |
2023-06-09 |
Neuropore Therapies, Inc. |
Spojevi kao modulatori signaliziranja tlr2
|
|
CN112189012B
(zh)
*
|
2018-04-10 |
2024-02-13 |
神经孔疗法股份有限公司 |
作为pi3激酶和自噬途径的调节剂的三取代芳基和杂芳基衍生物
|
|
SMT202500389T1
(it)
|
2018-12-28 |
2025-11-10 |
Deciphera Pharmaceuticals Llc |
Inibitori di csf1r per l'uso nel trattamento di tumori tenosinoviali a cellule giganti
|
|
CA3136102A1
(en)
|
2019-05-10 |
2020-11-19 |
Cersci Therapeutics, Inc. |
Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent
|
|
HRP20231310T1
(hr)
*
|
2019-05-10 |
2024-02-02 |
Deciphera Pharmaceuticals, Llc |
Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
|
|
HUE065486T2
(hu)
|
2019-05-10 |
2024-05-28 |
Deciphera Pharmaceuticals Llc |
Fenilaminopirimidinamid autophágia inhibitorok és azok felhasználási eljárásai
|
|
ES3075769T3
(en)
|
2019-05-10 |
2026-08-07 |
Janssen Biotech Inc |
Macrocyclic chelators and methods of use thereof
|
|
ES3072710T3
(en)
|
2019-06-17 |
2026-07-03 |
Deciphera Pharmaceuticals Llc |
Aminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
JP2022552655A
(ja)
|
2019-10-07 |
2022-12-19 |
キャリーオペ,インク. |
Gpr119アゴニスト
|
|
US12458630B2
(en)
|
2020-01-14 |
2025-11-04 |
The Regents Of The University Of California |
Combination therapy for cancer
|
|
EP4444310A4
(en)
|
2021-12-10 |
2025-11-19 |
Verastem Inc |
POLYTHERAPY FOR THE TREATMENT OF ABNORMAL CELL GROWTH
|